455 related articles for article (PubMed ID: 31060732)
1. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review.
Thiruvenkatarajan V; Meyer EJ; Nanjappa N; Van Wijk RM; Jesudason D
Br J Anaesth; 2019 Jul; 123(1):27-36. PubMed ID: 31060732
[TBL] [Abstract][Full Text] [Related]
2. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Burke KR; Schumacher CA; Harpe SE
Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
[TBL] [Abstract][Full Text] [Related]
3. Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors.
Fleming N; Hamblin PS; Story D; Ekinci EI
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32302001
[TBL] [Abstract][Full Text] [Related]
4. Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature.
Bonora BM; Avogaro A; Fadini GP
Diabetes Obes Metab; 2018 Jan; 20(1):25-33. PubMed ID: 28517913
[TBL] [Abstract][Full Text] [Related]
5. Sodium-Glucose Co-transporter-2 Inhibitors Induced Diabetic Ketoacidosis in Patients Undergoing Bariatric Surgery: a Systematic Review of Case Reports and Case Series.
Gokhare Viswanath N; Sharma M; Bandlamudi N; Idris I; Singhal R; Mahawar K; Madhok B
Obes Surg; 2023 Jan; 33(1):339-344. PubMed ID: 36418772
[TBL] [Abstract][Full Text] [Related]
6. Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression.
Musso G; Sircana A; Saba F; Cassader M; Gambino R
PLoS Med; 2020 Dec; 17(12):e1003461. PubMed ID: 33373368
[TBL] [Abstract][Full Text] [Related]
7. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence.
Mehta PB; Robinson A; Burkhardt D; Rushakoff RJ
Endocr Pract; 2022 Sep; 28(9):884-888. PubMed ID: 35753675
[TBL] [Abstract][Full Text] [Related]
8. Postoperative euglycaemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors (gliflozins): a report of two cases and review of the literature.
Chacko B; Whitley M; Beckmann U; Murray K; Rowley M
Anaesth Intensive Care; 2018 Mar; 46(2):215-219. PubMed ID: 29519226
[TBL] [Abstract][Full Text] [Related]
9. Acute Metabolic Emergencies in Diabetes: DKA, HHS and EDKA.
Muneer M; Akbar I
Adv Exp Med Biol; 2021; 1307():85-114. PubMed ID: 32488607
[TBL] [Abstract][Full Text] [Related]
10. Life-Threatening Complications Related to Delayed Diagnosis of Euglycemic Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Report of 2 Cases.
Goto S; Ishikawa JY; Idei M; Iwabuchi M; Namekawa M; Nomura T
Am J Case Rep; 2021 Mar; 22():e929773. PubMed ID: 33723205
[TBL] [Abstract][Full Text] [Related]
11. Sodium-Glucose Cotransporter-2 Inhibitor-associated Euglycemic Diabetic Ketoacidosis: Lessons From a Case Series of 4 Patients Undergoing Coronary Artery Bypass Grafting Surgery.
Chaudhry A; Roels C; Lee J
Can J Diabetes; 2022 Dec; 46(8):843-850. PubMed ID: 36068154
[TBL] [Abstract][Full Text] [Related]
12. [Sodium glucose cotransporter-2 inhibitors (SGLT2i) and risk of ketoacidosis].
Nordvall LM; Ekstedt B; Schneede J
Lakartidningen; 2024 Feb; 121():. PubMed ID: 38369865
[TBL] [Abstract][Full Text] [Related]
13. The catabolic triad: case report of fasting, major cardiac surgery and sodium-glucose co-transporter 2 inhibitors leading to perioperative euglycaemic ketoacidosis.
Smyth CC; Collins M; McCarthy J; Galvin S
Interact Cardiovasc Thorac Surg; 2021 Aug; 33(3):494-495. PubMed ID: 33961026
[TBL] [Abstract][Full Text] [Related]
14. Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors.
Isaacs M; Tonks KT; Greenfield JR
Intern Med J; 2017 Jun; 47(6):701-704. PubMed ID: 28580740
[TBL] [Abstract][Full Text] [Related]
15. [Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].
Menghoum N; Oriot P; Hermans MP; Mariage JL
Rev Med Interne; 2020 Apr; 41(4):226-231. PubMed ID: 31866073
[TBL] [Abstract][Full Text] [Related]
16. Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases.
Wang L; Voss EA; Weaver J; Hester L; Yuan Z; DeFalco F; Schuemie MJ; Ryan PB; Sun D; Freedman A; Alba M; Lind J; Meininger G; Berlin JA; Rosenthal N
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1620-1628. PubMed ID: 31456304
[TBL] [Abstract][Full Text] [Related]
17. [Sodium-glucose-cotransporter 2 inhibitor-associated euglycaemic diabetic ketoacidosis].
Fisker F; Møller N; Lauritzen ES
Ugeskr Laeger; 2019 May; 181(21):. PubMed ID: 31124439
[TBL] [Abstract][Full Text] [Related]
18. SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission.
Hamblin PS; Wong R; Ekinci EI; Fourlanos S; Shah S; Jones AR; Hare MJL; Calder GL; Epa DS; George EM; Giri R; Kotowicz MA; Kyi M; Lafontaine N; MacIsaac RJ; Nolan BJ; O'Neal DN; Renouf D; Varadarajan S; Wong J; Xu S; Bach LA
J Clin Endocrinol Metab; 2019 Aug; 104(8):3077-3087. PubMed ID: 30835263
[TBL] [Abstract][Full Text] [Related]
19. SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort.
Ata F; Yousaf Z; Khan AA; Razok A; Akram J; Ali EAH; Abdalhadi A; Ibrahim DA; Al Mohanadi DHSH; Danjuma MI
Sci Rep; 2021 May; 11(1):10293. PubMed ID: 33986421
[TBL] [Abstract][Full Text] [Related]
20. Perioperative implications of sodium-glucose cotransporter-2 inhibitors: a case series of euglycemic diabetic ketoacidosis in three patients after cardiac surgery.
Lau A; Bruce S; Wang E; Ree R; Rondi K; Chau A
Can J Anaesth; 2018 Feb; 65(2):188-193. PubMed ID: 29168157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
